Triveni Engineering and Industries Ltd
TRIVENITriveni Engineering and Industries Ltd's earnings have outrun its stock. EPS grew +10.5% in a year against a −35.0% price move.
The sharpest disagreement: profits are rising, but only 20% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (18 weeks in) while the P/E sits at the 81st percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +73.8% year on year, and 20% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Triveni Engineering and Industries Ltd trades at ₹222, in a confirmed uptrend and 18 weeks into that stage. That is −6.5% against its own 200-day average. It sits at 0% of a 52-week range of ₹221 to ₹452. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (5 weeks and counting).
Today the stock is in a confirmed uptrend — week 18 of stage 2, confirmed. At ₹222 it trades −6.5% versus its 200-day average and sits at 0% of its 52-week range (₹221–₹452).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +454% while the NIFTY 500 moved +282% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (5 weeks and counting; last ahead the week of 2026-07-01) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Triveni Engineering and Industries Ltd trades at 18.6× P/E, at the pricey end of its own range (81st percentile). Its long-run median P/E is 8.9×, measured across 10.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 18.6× is at the pricey end of its own range (81st percentile), against a long-run median of 8.9× measured over 10.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +10.5% against a −35.0% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +3.5%/yr price move, ~−0.2%/yr came from earnings growth and ~+3.7 pp from the multiple (expanding); over 10y, of the +13.5%/yr price move, ~+9.2%/yr came from earnings growth and ~+4.3 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 96% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Triveni Engineering and Industries Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −41.6% at the trough to +29.1% off a 5-quarter-old trough, ROCE slipping at 7.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +4.6% | +1.9% | +5.0% | +12.0% |
| Profit | +13.0% | −46.9% | −1.8% | — |
| EPS | +10.5% | −46.9% | +0.2% | — |
| Share price | −35.0% | −9.3% | +3.5% | +13.5% |
4-Factor Sector Score
36.7/100 — rank 15 of 20 in Sugar · 82% evidence confidence
Triveni Engineering and Industries Ltd scores 36.7 out of 100 against the 20 companies it is compared with in Sugar, ranking 15. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 18 + 9.6 + 6.8 + 2.3 = 36.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Triveni Engineering and Industries Ltd reported ₹1,581 Cr of revenue in the Jun 26 quarter, +2.1% year on year. Over 10 years it has compounded at 12.0% a year. The last full year, FY26, came in at ₹5,952 Cr. The last four reported quarters add to ₹6,173 Cr.
FY26 revenue came in at ₹5,952 Cr (+4.6% on the year), capping 10 years at 12.0% compound. The latest quarter (Jun 26) printed ₹1,581 Cr, +2.1% year on year.
Pace check: the last four quarters averaged +4.8% growth against the decade's 12.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +4.0% over the last 4 quarters against +7.7%/yr over the last 8 — rolling over; TTM profit +29.1% vs −13.2%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Triveni Engineering and Industries Ltd's operating margin is 3.4% in the Jun 26 quarter, +1.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −0.9% to 18.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 3.4%, +1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −0.9%–18.0%.
Why the margin moved: operating margin went +1.0 pp year on year while gross margin went −0.3 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Triveni Engineering and Industries Ltd earned ₹3.6 Cr of net profit in the Jun 26 quarter, +73.8% year on year. Full-year FY26 profit was ₹269 Cr. That is 0.2% of the quarter's revenue. The same quarter a year earlier earned ₹2.1 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹3.6 Cr, +73.8% year on year. On the full year, FY26 printed ₹269 Cr (+13.0%).
Why profit moved: revenue contributed +2.1% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +48.7% vs revenue +4.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 20% of Triveni Engineering and Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹188 Cr of operating cash against ₹269 Cr of profit. After ₹171 Cr of capital spending, ₹17.0 Cr was left as free cash.
FY26: operating cash of ₹188 Cr against reported profit of ₹269 Cr, leaving free cash of ₹17.0 Cr after ₹171 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 20% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 20%: the cash cycle stretched 106 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 106 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Triveni Engineering and Industries Ltd's cash conversion cycle runs 241 days in FY26, up from 135 days in FY21. Capital spending ran ₹1,269 Cr over the last 3 years. At FY26 sales of ₹5,952 Cr each day of that cycle holds about ₹16.3 Cr, so roughly ₹3,930 Cr sits inside the business at any moment.
FY26: debtors at 34 days, inventory at 243 days — roughly 8.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 241 days, looser than FY21's 135.
The full loop: cash goes out to suppliers and production on day 0; stock waits 243 days to sell; customers pay about 34 days after that; and suppliers themselves are paid at 36 days — netting out to the 241-day cycle.
In money terms: at FY26 sales of ₹5,952 Cr, each day of the cycle holds about ₹16.3 Cr — so the 241-day loop keeps roughly ₹3,930 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹1,269 Cr over the last 3 fiscal years against ₹355 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹14.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Triveni Engineering and Industries Ltd earns a ROCE of 7% in FY26. That is up from a trough of −2% in FY15. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 4.5% net margin on 0.91× asset turns.
FY26 ROCE is 7%, recovered from a FY15 trough of −2% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 4.5% net margin × 0.91× asset turns × 1.95× balance-sheet leverage ≈ 8.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 96% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Triveni Engineering and Industries Ltd carries ₹2,161 Cr of borrowings against ₹3,343 Cr of equity in FY26, a debt-to-equity of 0.65. Operating profit covers the interest bill 4×. Over 5 years borrowings went from ₹990 Cr to ₹2,161 Cr. Capital spending ran ₹1,269 Cr across the last 3 of those years.
FY26: borrowings of ₹2,161 Cr against equity of ₹3,343 Cr — a debt-to-equity of 0.65. Operating profit covers the interest bill 4×. Over 5 years borrowings went from ₹990 Cr to ₹2,161 Cr while capital spending ran ₹1,269 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 96% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 2.9 points of Triveni Engineering and Industries Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 7.7% of the company. Domestic institutions moved −1.2 points over the same window, to 7.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +2.9 points over 8 quarters to 7.7%; Domestic institutions: −1.2 points over 8 quarters to 7.6%; Promoters: −0.4 points over 8 quarters to 60.6%.
Why the register moved: foreign institutions drove it (+2.9 points), absorbed on the other side by domestic institutions (−1.2 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Triveni Engineering and Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Andhra Sugars LtdANDHRSUGAR | 65.7/100Favorable setup83% evidence | FADING | 26.7/35 Revenue 22.1% · PAT 100% · OPM change -1.8 pp 83% evidence | 12.9/25 ROCE 8.5% · OPM 7.5% 95% evidence | 13.0/20 P/E 11.2× · PEG — 50% evidence | 13.1/20 RS sector 8.6% · RS bench 1.9% · 1Y 2.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 26.7 + 12.9 + 13 + 13.1 = 65.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2DCM Shriram LtdDCMSHRIRAM | 60.5/100Mixed-positive evidence100% evidence | ASLEEP | 23.8/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence | 13.0/25 ROCE 11.5% · OPM 9% 100% evidence | 16.8/20 P/E 11.8× · PEG 0.44 100% evidence | 6.9/20 RS sector -6.5% · RS bench -12% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.8 + 13 + 16.8 + 6.9 = 60.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.5% and the one-year return is -26%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Uttam Sugar Mills LtdUTTAMSUGAR | 58.4/100Mixed-positive evidence70% evidence | ASLEEP | 23.1/35 Revenue 19.2% · PAT 17.4% · OPM change 1 pp 83% evidence | 17.1/25 ROCE 11.5% · OPM 21% 95% evidence | 11.2/20 P/E 8.4× · PEG — 15% evidence | 7.0/20 RS sector -9.1% · RS bench -8.2% · 1Y -17.3%5 of 10 weeks ahead 70% evidence |
| Exact sum: 23.1 + 17.1 + 11.2 + 7 = 58.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4M.V.K. Agro Food Product LtdMVKAGRO | 56.6/100Thin evidence · provisional52% evidence | ASLEEP | 18.2/35 Revenue — · PAT — · OPM change 17 pp 32% evidence | 17.6/25 ROCE 14.4% · OPM 22% 95% evidence | 8.8/20 P/E 35.8× · PEG — 15% evidence | 12.0/20 RS sector 33.8% · RS bench -37.8% · 1Y 47.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.2 + 17.6 + 8.8 + 12 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Bannari Amman Sugars LtdBANARISUG | 55.0/100Mixed-positive evidence96% evidence | BASING | 17.9/35 Revenue 6.9% · PAT 42.3% · OPM change -9.7 pp 88% evidence | 14.9/25 ROCE 9.3% · OPM 1.3% 100% evidence | 9.6/20 P/E 29.5× · PEG 1.75 100% evidence | 12.6/20 RS sector 0.9% · RS bench -5% · 1Y -7.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 14.9 + 9.6 + 12.6 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Dalmia Bharat Sugar & Industries LtdDALMIASUG | 54.2/100Mixed-positive evidence96% evidence | ASLEEP | 9.6/35 Revenue -3.2% · PAT -37.7% · OPM change -2 pp 88% evidence | 13.1/25 ROCE 8.2% · OPM 17% 100% evidence | 14.3/20 P/E 12.3× · PEG 0.48 100% evidence | 17.2/20 RS sector 9.6% · RS bench 2.8% · 1Y -7.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 9.6 + 13.1 + 14.3 + 17.2 = 54.2 · Decision use: Price leads the evidence: RS versus the benchmark is 2.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Dhampur Sugar Mills LtdDHAMPURSUG | 52.4/100Mixed-positive evidence87% evidence | ASLEEP | 20.5/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence | 8.5/25 ROCE 6.4% · OPM 5.7% 95% evidence | 9.0/20 P/E 12.4× · PEG — 50% evidence | 14.4/20 RS sector 7% · RS bench 0.4% · 1Y -6.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 8.5 + 9 + 14.4 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8EID Parry (India) LtdEIDPARRY | 50.9/100Mixed-positive evidence72% evidence | ASLEEP | 19.9/35 Revenue 21.9% · PAT -22.2% · OPM change 0 pp 83% evidence | 16.9/25 ROCE 17% · OPM 8% 76% evidence | 9.6/20 P/E 20.6× · PEG — 50% evidence | 4.5/20 RS sector -20.5% · RS bench -18.4% · 1Y -35.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 19.9 + 16.9 + 9.6 + 4.5 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Balrampur Chini Mills LtdBALRAMCHIN | 50.3/100Mixed-positive evidence96% evidence | BREAKING OUT | 15.3/35 Revenue 15.8% · PAT -13.1% · OPM change -6 pp 88% evidence | 13.2/25 ROCE 9.3% · OPM 18% 100% evidence | 2.4/20 P/E 32.7× · PEG 2.21 100% evidence | 19.4/20 RS sector 24% · RS bench 16.5% · 1Y -0.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 13.2 + 2.4 + 19.4 = 50.3 · Decision use: Price leads the evidence: RS versus the benchmark is 16.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Dhampur Bio Organics LtdDBOL | 48.1/100Mixed-negative evidence72% evidence | ASLEEP | 21.0/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence | 6.1/25 ROCE 5% · OPM 1.7% 95% evidence | 9.7/20 P/E 25.4× · PEG — 15% evidence | 11.3/20 RS sector 7.7% · RS bench 1% · 1Y 10.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 6.1 + 9.7 + 11.3 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Avadh Sugar & Energy LtdAVADHSUGAR | 47.7/100Mixed-negative evidence83% evidence | BREAKING OUT | 8.9/35 Revenue 2.2% · PAT -34.8% · OPM change -4 pp 83% evidence | 11.6/25 ROCE 6.8% · OPM 18% 95% evidence | 8.1/20 P/E 16.1× · PEG — 50% evidence | 19.1/20 RS sector 24.1% · RS bench 16.2% · 1Y 8.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 8.9 + 11.6 + 8.1 + 19.1 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 16.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12Bajaj Hindusthan Sugar LtdBAJAJHIND | 47.6/100Mixed-negative evidence90% evidence | ASLEEP | 22.4/35 Revenue -2.2% · PAT 100% · OPM change 4 pp 88% evidence | 9.4/25 ROCE 2.3% · OPM 22% 100% evidence | 11.1/20 P/E 28.5× · PEG 1.32 100% evidence | 4.7/20 RS sector -21% · RS bench -12.7% · 1Y -33.2%6 of 11 weeks ahead 70% evidence |
| Exact sum: 22.4 + 9.4 + 11.1 + 4.7 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Godavari Biorefineries LtdGODAVARIB | 44.3/100Mixed-negative evidence76% evidence | ASLEEP | 20.1/35 Revenue 6.3% · PAT 100% · OPM change -4 pp 83% evidence | 9.2/25 ROCE 6.5% · OPM 15% 95% evidence | 8.7/20 P/E 39.7× · PEG — 15% evidence | 6.3/20 RS sector -2.3% · RS bench -8.3% · 1Y -17.1%2 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 9.2 + 8.7 + 6.3 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Zuari Industries LtdZUARIIND | 43.1/100Mixed-negative evidence62% evidence | ASLEEP | 18.8/35 Revenue 7.7% · PAT 100% · OPM change 1 pp 62% evidence | 8.1/25 ROCE 5.5% · OPM 11% 95% evidence | 11.5/20 P/E 6.6× · PEG — 15% evidence | 4.7/20 RS sector -26.8% · RS bench -10.8% · 1Y -2.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 18.8 + 8.1 + 11.5 + 4.7 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Triveni Engineering and Industries Ltdthis pageTRIVENI | 36.7/100Mixed-negative evidence82% evidence | ASLEEP | 18.0/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence | 9.6/25 ROCE 6.8% · OPM 3.4% 76% evidence | 6.8/20 P/E 18.6× · PEG — 50% evidence | 2.3/20 RS sector -33.2% · RS bench -3.8% · 1Y -39.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 9.6 + 6.8 + 2.3 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Davangere Sugar Company LtdDAVANGERE | 36.3/100Mixed-negative evidence70% evidence | 14.4/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence | 8.9/25 ROCE 5.6% · OPM 10.1% 95% evidence | 8.5/20 P/E 58.6× · PEG — 15% evidence | 4.5/20 RS sector -25% · RS bench -12.6% · 1Y -47%1 of 8 weeks ahead 70% evidence | |
| Exact sum: 14.4 + 8.9 + 8.5 + 4.5 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Magadh Sugar & Energy LtdMAGADSUGAR | 36.0/100Mixed-negative evidence77% evidence | ASLEEP | 6.4/35 Revenue -5.9% · PAT -41.3% · OPM change -5 pp 83% evidence | 11.9/25 ROCE 7.8% · OPM 27% 95% evidence | 10.1/20 P/E 11.1× · PEG — 50% evidence | 7.6/20 RS sector -19.1% · RS bench -0.8% · 1Y -11.1%2 of 10 weeks ahead 70% evidence |
| Exact sum: 6.4 + 11.9 + 10.1 + 7.6 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Dwarikesh Sugar Industries LtdDWARKESH | 35.1/100Thin evidence · provisional54% evidence | ASLEEP | 16.7/35 Revenue 20.1% · PAT -80% · OPM change -8.2 pp 31% evidence | 3.7/25 ROCE 5% · OPM -7.2% 80% evidence | 9.5/20 P/E 25.6× · PEG — 15% evidence | 5.2/20 RS sector -5.6% · RS bench -11.4% · 1Y -17.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 3.7 + 9.5 + 5.2 = 35.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Shree Renuka Sugars LtdRENUKA | 17.1/100Adverse evidence76% evidence | ASLEEP | 2.4/35 Revenue -15.2% · PAT -80% · OPM change -9.5 pp 88% evidence | 0.6/25 ROCE -3.1% · OPM 1.5% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.1/20 RS sector -12.9% · RS bench -18.2% · 1Y -29.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 2.4 + 0.6 + 10 + 4.1 = 17.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20DCM Shriram Industries LtdDCMSRIND | 43.1/100Thin evidence · provisional48% evidence | 12.3/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence | 14.0/25 ROCE 13.7% · OPM 1.8% 71% evidence | 8.8/20 P/E 8.2× · PEG — 50% evidence | 8.0/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence | |
| Exact sum: 12.3 + 14 + 8.8 + 8 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Triveni Engineering and Industries Ltd's share price today?
Triveni Engineering and Industries Ltd trades at ₹222, −35.0% over the past year. The company is valued at ₹4,881 Cr. The stock sits at 0% of its 52-week range of ₹221–₹452, −6.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 18 weeks in. — as of 31 July 2026.
What were Triveni Engineering and Industries Ltd's latest quarterly results?
Triveni Engineering and Industries Ltd reported revenue of ₹1,581 Cr and net profit of ₹3.6 Cr for the Jun 26 quarter. Revenue rose 2.1% and profit rose 73.8% year on year. Earnings per share were ₹0.17. The operating margin was 3.4%, 1.0 pp higher than a year earlier. — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's revenue?
Triveni Engineering and Industries Ltd reported revenue of ₹1,581 Cr in the Jun 26 quarter, +2.1% year on year. For the full FY26 fiscal year, revenue was ₹5,952 Cr (+4.6%). Over the last 10 years revenue compounded at 12.0% a year. — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's profit?
Triveni Engineering and Industries Ltd earned ₹3.6 Cr of net profit in the Jun 26 quarter, +73.8% year on year. Full-year FY26 profit was ₹269 Cr. The operating margin ran 3.4% in the latest quarter. — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's market cap?
Triveni Engineering and Industries Ltd's market capitalisation is ₹4,881 Cr at a share price of ₹222. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's P/E ratio?
Triveni Engineering and Industries Ltd trades at a P/E of 18.6×, at the 81st percentile of its own 10-year range, against a long-run median of 8.9×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Triveni Engineering and Industries Ltd pay a dividend?
Yes — Triveni Engineering and Industries Ltd's dividend payout was 10% of profit in FY26, and it recorded a payout in 9 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd overvalued?
On its own history, Triveni Engineering and Industries Ltd looks expensive against its own history: its P/E of 18.6× sits at the 81st percentile of its 10-year range (long-run median 8.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd growing?
Yes — Triveni Engineering and Industries Ltd is growing: latest-quarter revenue +2.1% year on year, profit +73.8%, and the margin +1.0 pp at 3.4%. The earnings engine currently reads: improving — as of 31 July 2026.
How is Triveni Engineering and Industries Ltd performing?
Triveni Engineering and Industries Ltd is in a confirmed uptrend, 18 weeks in. Its latest quarter's revenue rose 2.1% and profit rose 73.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Triveni Engineering and Industries Ltd in?
Turning around — profit growth swung from −41.6% at the trough to +29.1% off a 5-quarter-old trough, ROCE slipping at 7.0%. The read comes from the last 12 quarters of growth (revenue growth +4.0% latest, profit growth +29.1% latest, eps growth +28.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 18 of stage 2), trading −6.5% versus its 200-day average and at 0% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd beating the market?
Not lately — on a trailing-13-week view Triveni Engineering and Industries Ltd is currently behind the NIFTY 500 (5 weeks and counting; last ahead the week of 2026-07-01), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +454% against the NIFTY 500's +282% — ahead of the index over the full window. — as of 31 July 2026.
Will Triveni Engineering and Industries Ltd's share price go up?
This page publishes no price forecast for Triveni Engineering and Industries Ltd. What it measures instead: the share price is ₹222, the price is in a confirmed uptrend 18 weeks in. Its P/E of 18.6× sits at the 81st percentile of its own 10-year range. — as of 31 July 2026.
Who owns Triveni Engineering and Industries Ltd?
Promoters hold 60.6% of Triveni Engineering and Industries Ltd, foreign institutions 7.7%, domestic institutions 7.6% and the public 24.1% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 2.9 points over 8 quarters. — as of 31 July 2026.
Does Triveni Engineering and Industries Ltd have too much debt?
It is moderate — Triveni Engineering and Industries Ltd's debt-to-equity is 0.65, and operating profit covers the interest bill 4×. FY26 borrowings were ₹2,161 Cr against equity of ₹3,343 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's capex?
Triveni Engineering and Industries Ltd spent ₹1,269 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹171 Cr, with ₹14.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Triveni Engineering and Industries Ltd's cash flow?
Triveni Engineering and Industries Ltd generated ₹188 Cr of operating cash flow in FY26 and ₹17.0 Cr of free cash flow after ₹171 Cr of capital spending. Reported profit that year was ₹269 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 20% of Triveni Engineering and Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹188 Cr against reported profit of ₹269 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Triveni Engineering and Industries Ltd in its business cycle?
Triveni Engineering and Industries Ltd's FY26 operating margin was 7.0%, against a 13-year band of −0.9%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 3.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Triveni Engineering and Industries Ltd story?
The sharpest disagreement: profits are rising, but only 20% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Triveni Engineering and Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Triveni Engineering and Industries Ltd's earnings have outrun its stock. EPS grew +10.5% in a year against a −35.0% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.